Physician profile
John J Saad
NPI 1710942198
$4,870.61
in general payments reported to CMS, 2019-2025
15 companies · $4,338 in 2025
The $4,338 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $49.69 · 2021: $36.08 · 2022: $67.13 · 2023: $131 · 2024: $107 · 2025: $4,338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,182 · Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,182.32 |
| Food and Beverage | $393.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,241.50 | 2023-2025 | Amnioexcel Plus, Amnioexcel, Integra |
| Optinose US, INC. | $222.46 | 2019-2025 | |
| Glaxosmithkline, LLC. | $115.93 | 2023-2025 | Nucala |
| Ambu INC. | $48.76 | 2023 | |
| Stryker Corporation | $36.08 | 2021 | |
| Kerecis Limited | $28.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hospira, INC. | $27.21 | 2022 | |
| Aroa Biosurgery Incorporated | $25.77 | 2022 | |
| Neurent Medical Limited | $25.48 | 2023 | Neuromark Device, Neuromark Radiofrequency Console |
| Arbor Pharmaceuticals, INC. | $19.16 | 2019 | |
| Medtronic, INC. | $18.81 | 2025 | Pteye Parathyroid Detection System |
| Baxter Healthcare | $17.46 | 2019 | |
| Hikma Pharmaceuticals USA | $16.18 | 2024 | Ryaltris |
| Olympus America INC. | $14.15 | 2022 | |
| Misonix INC | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.